Experimental Studies on Venous Thrombosis: Effect of Coagulants, Procoagulants and Vessel Contusion

Summary

We have examined the relative contribution of stasis, activated coagulants, procoagulants and vessel wall damage in the pathogenesis of experimental venous thrombosis. Using a Wessler stasis model in rabbits, we found an inverse correlation between duration of stasis and the amount of Contact Factor and Factor Xa required to produce a stasis thrombus. However, the slope of the dose-response curve for producing thrombi was different with these two coagulants. The infusion of Factor IX complex was also thrombogenic in this model despite prolonged circulation prior to stasis, implying that high levels of multiple procoagulants may be thrombogenic. In contrast, Factor VIII concentrates or a purified Factor IX preparation did not give thrombi under these conditions.

When the vessel wall was crushed mechanically, followed by restored blood flow and subsequent stasis, there was essentially no formation of thrombi over the time course of the experiments. Scanning electron microscopy demonstrated that although the endothelium was swollen and damaged, there was usually no exposure of sub-endothelium and no adherence platelets. Where there was definite disruption of the endothelium, activated platelets could be seen adhering to the vessel wall. However, the blood in the segments remained fluid over a period of 30 min, despite the presence of adherent platelets.

Our experiments demonstrated that the combination of vessel wall damage and stasis was relatively ineffective in producing venous thrombosis. In contrast, high levels of zymogens or small amounts of activated clotting factors, combined with local stasis, is a very effective thrombogenic stimulus in the venous system.

keywords

Experimental venous thrombosis - Factor Xa - Contact factor - IX complex - Vessel wall

• References

• 1 Poole JC F. Historical introduction. In: Biology and Pathology of the Vessel Wall: A modern appraisal Woolf N. (ed). 1-14 Praeger, New York: 1983
• 2 Kakkar VV, Day TK. The vessel wall in venous thrombosis. In: Biology and Pathology of the Vessel Wall: A modern appraisal Woolf N. (ed). 229-242 Praeger, New York: 1983
• 3 Wessler S. Thrombosis in the presence of vascular stasis. Am J Med 1962; 33: 648-666
• 4 Virchow R. Thrombosis und Embolie. In: Gesammelte Abhandlungen zur wissenschaftlichen Medicin. p 148 Meidinger Sohn u. Comp; Frankfurt: 1856
• 5 Thomas DP. Pathogenesis of venous thrombosis. In: Haemostasis and Thrombosis Bloom AL, Thomas DP. (eds). 637-645 Churchill Livingstone; London & Edinburgh: 1981
• 6 Brozovic M. Physiological mechanisms in coagulation and fibrinolysis. Br Med Bull 1977; 33: 231-238
• 7 Kasper K. Thromboembolic complications. Thrombos Diathes Haemorrh 1975; 33: 640-644
• 8 Wessler S, Reiner L, Freiman DG, Reimer SM, Lertzman M. Serum-induced thrombosis. Studies of its induction and evolution under controlled conditions in vivo. Circulation 1959; 20: 864-874
• 9 Spaet TH. Studies on the in vivo behaviour of blood coagulation product I in rats. Thrombos Diathes Haemorrh 1962; 8: 276-285
• 10 Deykin D. The role of the liver in serum-induced hypercoagulability. J Clin Invest 1966; 45: 256-265
• 11 Wessler S, Yin ET, Gaston LW, Nicol I. A distinction between the role of precursor and activated forms of clotting factors in the genesis of stasis thrombi. Thrombos Diathes Haemorrh 1967; 18: 12-23
• 12 Nossel HL. “The Contact Phase of Blood Coagulation”. Blackwell Scientific Publications; Oxford: 1964
• 13 Fujikawa K, Thompson AR, Legaz ME, Meyer RG, Davie EW. Isolation and characterization of bovine factor IX (Christmas factor). Biochemistry 1973; 12: 4938
• 14 Ménaché D, Behre HE, Orthner CL, Nunez H, Anderson HD, Triantaphyllopoulos DC, Kosow DP. Coagulation Factor IX Concentrate. Method of preparation and assessment of potential in vivo thrombogenicity in animal models. Blood 1984; 64: 1220-1227
• 15 Denson KW E. The specific assay of Prower-Stuart factor and factor VII. Acta Haematol 1961; 25: 105-120
• 16 Prowse CV, Williams AE. A comparison of in vitro and in vivo thrombogenic activity of Factor IX concentrates using stasis (Wessler) and non-stasis rabbit models. Thromb Haemostas 1980; 44: 81-86
• 17 Giles AR, Nesheim ME, Hoogendoorn H, Tracy PB, Mann KG. The coagulant-active phospholipid content is a major determinant of in vivo thrombogenicity of prothrombin complex (Factor IX) concentrates in rabbits. Blood 1982; 59: 401-407
• 18 Magner A, Aronson DL. Toxicity of Factor IX concentrates. Devel Biol Stand 1979; 44: 185-190
• 19 Deykin D, Cochios F, Decamp G, Lopez A. Hepatic removal of activated Factor X by the perfused rabbit liver. Am J Physiol 1968; 214: 414-419
• 21 Bajaj SP. Cooperative Ca⁺⁺ binding to human Factor IX. J Biol Chem 1982; 257: 4127-4132
• 22 Breen FA, Tullis JL. Prothrombin complex concentrates in treatment of Christmas disease and allied disorders. JAMA 1969; 208: 1848-1852
• 23 Lusher JM, Shapiro SS, Palascak JE, Rao AV, Levine PH, Blatt PM. The Hemophilia study group. Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII. A multicenter therapeutic trial. N Engl J Med 1980; 303: 421-425
• 24 Nossel HL, Nemetz J. A normal inhibition of the blood coagulation contact reaction product. Blood 1965; 25: 712-723
• 25 Gitel SN, Stephenson RC, Wessler S. In vitro and in vivo correlation of clotting protease activity: Effect of heparin. Proc Natl Acad Sci USA 1977; 74: 3028-3032
• 26 Biggs R, Denson KW E, Akman N, Borrett R, Haddon M. Br J Haematol 1970; 19: 283-305
• 27 Hume M, Sevitt S, Thomas DP. “Venous Thrombosis and Pulmonary Embolism”. Harvard University Press; Cambridge, Massachusetts: 1970
• 28 Sevitt S. Pathology and pathogenesis of deep vein thrombi. In Bergan JJ, Yao JS T. eds Venous Problems, Year Book Medical Publications; Chicago: 1978
• 29 Stehbens WE. Reaction of venous endothelium to injury. Lab Invest 1965; 14: 449-459
• 30 Ashford TP, Freiman DG. The role of the endothelium in the initial phases of thrombosis. Am J Pathol 1967; 50: 257-273
• 31 Hewson W. An experimental inquiry into the properties of the blood. T. Cadell, London 1771: 27
• 32 Lister J. On the coagulation of the blood. Proc Roy Soc Lond 1863; 12: 580